Tag: intranasal drug delivery devices market outlook

  • Global Intranasal Drug Delivery Devices  Market Report 2024: Size, Drivers, And Top Segments

    Global Intranasal Drug Delivery Devices Market Report 2024: Size, Drivers, And Top Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Intranasal Drug Delivery Devices Market from 2024 to 2033?

    The intranasal drug delivery devices market has seen notable growth, forecasted to grow from $55.27 billion in 2023 to $60.27 billion in 2024 at a CAGR of 9.0%. Growth factors include rising cases of chronic respiratory conditions, patient compliance, self-administration convenience, pediatric use, and broader treatment indications.

    The intranasal drug delivery devices market is forecasted to grow to $84.51 billion by 2028, with a CAGR of 8.8%. Growth factors include an aging population, increasing respiratory disorders, the rising incidence of neurological conditions, personalized medicine trends, preventive healthcare, and expanding access in emerging markets. Major trends include advances in formulation technologies, focus on pediatric and geriatric populations, rise in self-administration devices, nasal powder inhalers, and incorporation of biologics and peptides.

    Claim Your Free Sample of the Global Intranasal Drug Delivery Devices Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp

    What Key Factors Are Fueling the Growth of the Intranasal Drug Delivery Devices Market?

    The growing prevalence of chronic diseases is expected to drive the intranasal drug delivery devices market. Chronic diseases require ongoing medical management, and intranasal drug delivery devices provide a non-invasive, effective way to administer medications. In September 2022, the National Institutes of Health projected that by 2050, the number of people aged 50 and older in the US with at least one chronic condition would rise by 99.5%, further boosting the demand for intranasal drug delivery devices.

    What Are the Major Segments of the Intranasal Drug Delivery Devices Market?

    1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products

    2) By Dosage: Unit-Dose, Multi-Dose

    3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications

    4) By End User: Hospitals, Clinics, Homecare, Other End Users

    What New Trends Are Transforming the Intranasal Drug Delivery Devices Market?

    In the nasal drug delivery technology market, companies are working on developing advanced drug administration methods to strengthen their market position. For example, in January 2023, AptarGroup, Inc. launched the recyclable, metal-free APF Futurity nasal spray, which delivers nasal saline and over-the-counter formulations. This product is made from polyolefin materials, promoting sustainability by eliminating metal components and facilitating easier recycling, with Class AA certification for European recycling streams.

    Order Now for Fast Delivery of Your Intranasal Drug Delivery Devices Market Report!

    https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

    Which Regions Are Driving Growth in the Intranasal Drug Delivery Devices Market?

    North America was the largest region in the intranasal drug delivery devices market in 2023. The regions covered in the intranasal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Intranasal Drug Delivery Devices Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the intranasal drug delivery devices market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Intranasal Drug Delivery Devices Market Include

    1. Intranasal Drug Delivery Devices Market Executive Summary

    2. Intranasal Drug Delivery Devices Market Segments

    3. Intranasal Drug Delivery Devices Market Size And Template Market Growth Rate

    4. Key Intranasal Drug Delivery Devices Market Trends

    5. Major Intranasal Drug Delivery Devices Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Intranasal Drug Delivery Devices Market

    26. Top Intranasal Drug Delivery Devices Companies

    27. Intranasal Drug Delivery Devices Market Opportunities And Strategies

    28. Intranasal Drug Delivery Devices Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Electrophysiology Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/electrophysiology-devices-and-equipment-global-market-report

    Electrosurgical Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/electrosurgical-devices-and-equipment-global-market-report

    ENT Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ent-devices-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Top 5 Insights From The Intranasal Drug Delivery Devices Market Report 2024

    Top 5 Insights From The Intranasal Drug Delivery Devices Market Report 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Intranasal Drug Delivery Devices Global Market Report 2024, the intranasal drug delivery devices market is expected to show promising growth in the forecast period.

    Market Overview
    The intranasal drug delivery devices market has experienced robust growth in recent years. From a market size of $55.27 billion in 2023, it is projected to reach $60.27 billion in 2024, growing at a compound annual growth rate (CAGR) of 9.0%. This growth is fueled by several factors, including the rising incidence of chronic respiratory diseases, patient preferences, and the convenience of self-administration. The market is expected to expand further to $84.51 billion by 2028, with a CAGR of 8.8%.

    Key Drivers of Market Growth
    Rising Chronic Diseases

    • Chronic diseases, requiring long-term medication and management, significantly boost demand for intranasal drug delivery devices. These devices offer a non-invasive, efficient means of administering medications, promoting quick absorption.
    • The National Institutes of Health (NIH) forecasts a dramatic increase in chronic illnesses in the U.S., with those aged 50 and older experiencing a near doubling of chronic conditions by 2050.

    Growing Geriatric Population

    • The aging population globally is a significant driver of market growth, with increased respiratory and neurological issues necessitating advanced drug delivery solutions.

    Advancements in Technology

    • Innovations in drug formulation and delivery methods are expanding the applications of intranasal devices, including in neurological disorders and personalized medicine.

    View More On The Intranasal Drug Delivery Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

    Innovative Trends and Developments
    Technological Advancements

    • Companies are developing new, advanced intranasal devices to maintain a competitive edge. For example, AptarGroup, Inc. launched the APF Futurity, a recyclable, metal-free multidose nasal spray in January 2023. This product, made from polyolefin materials, enhances recycling efficiency and supports sustainability.

    Acquisitions and Expansions

    • Sandoz AG’s acquisition of Coalesce Product Development Limited in March 2022 highlights the industry’s strategic moves to enhance inhalation drug delivery capabilities and expand product portfolios.

    Market Segmentation
    By Product

    • Powder Delivery Device
    • Liquid Delivery Device
    • Pressurized Metered-Dose Inhalers
    • Other Products

    By Dosage

    • Unit-Dose
    • Multi-Dose

    By Application

    • Chronic Obstructive Pulmonary Disease (COPD)
    • Rhinitis
    • Cystic Fibrosis
    • Nasal Congestion
    • Asthma
    • Other Applications

    By End User

    • Hospitals
    • Clinics
    • Homecare
    • Other End Users

    Regional Insights
    In 2023, North America led the intranasal drug delivery devices market, reflecting the region’s advanced healthcare infrastructure and high demand for innovative drug delivery solutions.

    Conclusion
    The intranasal drug delivery devices market is poised for significant growth, driven by increasing chronic disease prevalence, advancements in technology, and expanding applications in healthcare. With ongoing innovations and strategic acquisitions, the market is set to continue its upward trajectory, providing more efficient and convenient drug delivery solutions globally.

    Request A Sample Of The Global Intranasal Drug Delivery Devices Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13463&type=smp

  • Global Intranasal Drug Delivery Devices Market Key Insights 2024-2033

    Global Intranasal Drug Delivery Devices Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Intranasal Drug Delivery Devices Global Market Report 2024, the intranasal drug delivery devices market is expected to show promising growth in the forecast period.

    Introduction

    The intranasal drug delivery devices market has experienced robust growth in recent years, with a projected increase from $55.27 billion in 2023 to $60.27 billion in 2024, representing a compound annual growth rate (CAGR) of 9.0%. This growth is fueled by various factors, including the rising prevalence of chronic diseases and advancements in drug delivery technologies.

    Key Drivers of Market Growth

    Rise in Chronic Respiratory Diseases

    • Increasing prevalence of conditions like COPD and asthma.
    • Intranasal devices offer effective treatment options.

    Patient Preference and Compliance

    • Patients prefer non-invasive delivery methods.
    • Compliance increases with user-friendly devices.

    Convenience in Self-Administration

    • Ease of use promotes self-administration.
    • Reduces reliance on healthcare professionals.

    View More On The Intranasal Drug Delivery Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report

    Pediatric Applications

    • Intranasal delivery is suitable for pediatric patients.
    • Non-threatening method for children.

    Market Expansion in Allergic Rhinitis Treatment

    • Growing demand for allergy treatments.
    • Intranasal devices offer targeted relief.

    Future Market Projections

    The market is poised for continued strong growth, reaching $84.51 billion by 2028 with a CAGR of 8.8%.

    Key Growth Factors

    • Increasing Geriatric Population: Higher demand for chronic disease management.
    • Rising Global Respiratory Issues: Addressing respiratory health remains a priority.
    • Expanding Applications in Neurological Disorders: Intranasal delivery for neurological treatments.
    • Personalized Medicine Trends: Tailored treatments drive device innovation.
    • Preventive Healthcare Initiatives: Focus on early intervention and disease prevention.
    • Market Penetration in Emerging Economies: Growing healthcare infrastructure in developing nations.

    Major Trends

    • Advances in Formulation Technologies: Enhanced drug delivery systems.
    • Focus on Pediatric and Geriatric Applications: Tailoring devices for different age groups.
    • Rise in Self-Administration Devices: Empowering patients with convenient options.
    • Nasal Powder Inhalers: Alternative delivery method gaining traction.
    • Incorporation of Biologics and Peptides: Expanding treatment options with innovative formulations.

    Rising Prevalence of Chronic Diseases Fuels Market Growth

    The increasing prevalence of chronic diseases is a significant driver for the intranasal drug delivery devices market.

    Impact of Chronic Diseases

    • Chronic illnesses require ongoing management.
    • Intranasal devices offer convenient medication delivery.

    Example: NIH Report on Aging Population

    • Predicts a nearly 100% increase in chronic illnesses in the US by 2050.
    • Highlights the need for efficient drug delivery solutions.

    Innovative Intranasal Drug Delivery Technology

    Pharmaceutical companies are investing in innovative technologies to improve drug delivery.

    Example: AptarGroup’s APF Futurity

    • Recyclable, metal-free nasal spray for over-the-counter formulations.
    • Promotes sustainability and recycling efforts.

    Strategic Acquisitions Drive Market Expansion

    Companies are leveraging acquisitions to strengthen their positions and expand offerings.

    Example: Sandoz AG and Coalesce Product Development Limited

    • Acquisition enhances Sandoz’s inhalation drug delivery capabilities.
    • Accelerates development and commercialization of intranasal devices.

    Market Segmentation

    The intranasal drug delivery devices market is segmented based on various factors.

    By Product

    • Powder Delivery Device
    • Liquid Delivery Device
    • Pressurized Metered-Dose Inhalers
    • Other Products

    By Dosage

    • Unit-Dose
    • Multi-Dose

    By Application

    • Chronic Obstructive Pulmonary Disease (COPD)
    • Rhinitis
    • Cystic Fibrosis
    • Nasal Congestion
    • Asthma
    • Other Applications

    By End User

    • Hospitals
    • Clinics
    • Homecare
    • Other End Users

    Regional Insights

    • North America: Dominated the market in 2023.
    • Asia-Pacific: Emerging as a significant market with growing healthcare infrastructure.

    Conclusion

    The intranasal drug delivery devices market is experiencing robust growth, driven by increasing chronic diseases, technological advancements, and strategic initiatives. With a focus on innovation and expanding applications, the market is poised for substantial growth in the coming years, providing improved treatment options for patients worldwide.

    Request A Sample Of The Global Intranasal Drug Delivery Devices Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13463&type=smp